1 1 Elysian Medical Group Ltd 11468553 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is Medical services and Aesthetics Digita Accounts Production Advanced 6.30.9574.0 true 11468553 2023-08-01 2024-07-31 11468553 2024-07-31 11468553 bus:OrdinaryShareClass1 2024-07-31 11468553 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 11468553 core:FurnitureFittingsToolsEquipment 2024-07-31 11468553 core:OtherPropertyPlantEquipment 2024-07-31 11468553 bus:SmallEntities 2023-08-01 2024-07-31 11468553 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 11468553 bus:FilletedAccounts 2023-08-01 2024-07-31 11468553 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 11468553 bus:RegisteredOffice 2023-08-01 2024-07-31 11468553 bus:CompanySecretaryDirector1 2023-08-01 2024-07-31 11468553 bus:Director2 2023-08-01 2024-07-31 11468553 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 11468553 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 11468553 bus:Agent1 2023-08-01 2024-07-31 11468553 core:FurnitureFittings 2023-08-01 2024-07-31 11468553 core:FurnitureFittingsToolsEquipment 2023-08-01 2024-07-31 11468553 core:OtherPropertyPlantEquipment 2023-08-01 2024-07-31 11468553 core:PlantMachinery 2023-08-01 2024-07-31 11468553 countries:EnglandWales 2023-08-01 2024-07-31 11468553 2023-07-31 11468553 core:FurnitureFittingsToolsEquipment 2023-07-31 11468553 core:OtherPropertyPlantEquipment 2023-07-31 11468553 2022-08-01 2023-07-31 11468553 2023-07-31 11468553 bus:OrdinaryShareClass1 2023-07-31 11468553 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 11468553 core:FurnitureFittingsToolsEquipment 2023-07-31 11468553 core:OtherPropertyPlantEquipment 2023-07-31 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 11468553

Elysian Medical Group Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 July 2024

 

Elysian Medical Group Ltd

Contents

Company Information

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 5

 

Elysian Medical Group Ltd

Company Information

Directors

Dr Gopal Chandra Sinha

Dr Pamadeth Shobha

Company secretary

Dr Gopal Chandra Sinha

Registered office

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

Accountants

Charles Rippin & Turner Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

 

Elysian Medical Group Ltd

(Registration number: 11468553)
Abridged Balance Sheet as at 31 July 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

46,914

53,321

Current assets

 

Cash at bank and in hand

 

20,050

6,663

Creditors: Amounts falling due within one year

(25,845)

(24,059)

Net current liabilities

 

(5,795)

(17,396)

Total assets less current liabilities

 

41,119

35,925

Accruals and deferred income

 

(2,713)

(2,583)

Net assets

 

38,406

33,342

Capital and reserves

 

Called up share capital

5

2

2

Retained earnings

38,404

33,340

Shareholders' funds

 

38,406

33,342

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 April 2025 and signed on its behalf by:
 

.........................................
Dr Gopal Chandra Sinha
Company secretary and director

 

Elysian Medical Group Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

These financial statements were authorised for issue by the Board on 28 April 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Elysian Medical Group Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

20% Reducing balance

Plant and machinery

20% Reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2023 - 1).

 

Elysian Medical Group Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 August 2023

44,069

20,744

64,813

Disposals

(7,311)

(3,295)

(10,606)

At 31 July 2024

36,758

17,449

54,207

Depreciation

At 1 August 2023

7,343

4,149

11,492

Charge for the year

4,412

1,995

6,407

Eliminated on disposal

(7,311)

(3,295)

(10,606)

At 31 July 2024

4,444

2,849

7,293

Carrying amount

At 31 July 2024

32,314

14,600

46,914

At 31 July 2023

36,726

16,595

53,321

5

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary share capital of £1 each

2

2

2

2